Works by Auwärter, Volker

Results: 127
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study.

    Published in:
    Drug Testing & Analysis, 2024, v. 16, n. 9, p. 1002, doi. 10.1002/dta.3622
    By:
    • Angerer, Verena;
    • Schmid, Yasmin;
    • Franz, Florian;
    • Gnann, Heike;
    • Speer, Jan Manuel;
    • Gnann, Anke;
    • Helmecke, Stephan;
    • Buchwald, Armin;
    • Brandt, Simon D.;
    • Passie, Torsten;
    • Liechti, Matthias E.;
    • Auwärter, Volker
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Structure elucidation of the novel synthetic cannabinoid Cumyl‐To s yl‐ I n dazole‐3‐ C a rbox a mide (Cumyl‐TsINACA) found in illicit products in Germany.

    Published in:
    Drug Testing & Analysis, 2022, v. 14, n. 8, p. 1387, doi. 10.1002/dta.3261
    By:
    • Pulver, Benedikt;
    • Schönberger, Torsten;
    • Weigel, Diana;
    • Köck, Matthias;
    • Eschenlohr, Yvonne;
    • Lucas, Tobias;
    • Podlesnik, Nika;
    • Opatz, Till;
    • Dreiseitel, Wolfgang;
    • Pütz, Michael;
    • Schäper, Jan;
    • Jacobsen‐Bauer, Andrea;
    • Auwärter, Volker;
    • Westphal, Folker
    Publication type:
    Article
    22
    23
    24
    25
    26

    Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

    Published in:
    Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1412, doi. 10.1002/dta.3054
    By:
    • Grafinger, Katharina Elisabeth;
    • Vandeputte, Marthe M.;
    • Cannaert, Annelies;
    • Ametovski, Adam;
    • Sparkes, Eric;
    • Cairns, Elizabeth;
    • Juchli, Patrick Osamu;
    • Haschimi, Belal;
    • Pulver, Benedikt;
    • Banister, Samuel D.;
    • Stove, Christophe P.;
    • Auwärter, Volker
    Publication type:
    Article
    27

    Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay

    Published in:
    Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1402, doi. 10.1002/dta.3035
    By:
    • Grafinger, Katharina Elisabeth;
    • Cannaert, Annelies;
    • Ametovski, Adam;
    • Sparkes, Eric;
    • Cairns, Elizabeth;
    • Banister, Samuel D.;
    • Auwärter, Volker;
    • Stove, Christophe P.
    Publication type:
    Article
    28

    Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptors

    Published in:
    Drug Testing & Analysis, 2021, v. 13, n. 7, p. 1383, doi. 10.1002/dta.3037
    By:
    • Pike, Edward;
    • Grafinger, Katharina Elisabeth;
    • Cannaert, Annelies;
    • Ametovski, Adam;
    • Luo, Jia Lin;
    • Sparkes, Eric;
    • Cairns, Elizabeth A.;
    • Ellison, Ross;
    • Gerona, Roy;
    • Stove, Christophe P.;
    • Auwärter, Volker;
    • Banister, Samuel D.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50